SEC v. Trijya Vakil, Neeraj Visen — U.S. Securities and Exchange Commission Litigation Release No. 26348, dated July 11, 2025.
The SEC charged Trijya Vakil, a former Senior Director at Elanco Animal Health, and her friend Neeraj Visen with insider trading. Vakil learned of Elanco's impending acquisition of Kindred Biosciences while working on due diligence and traded on this nonpublic information. She also tipped Visen, who also traded, resulting in ill-gotten gains for both.
Imagine you work for a big company that's planning to buy a smaller company. You find out about this secret plan before anyone else. It's like knowing a surprise party is happening before the guest of honor. If you buy stock in the smaller company because you know it's about to be bought (and its stock price will go up), that's insider trading. It's not fair to others who don't have that secret information. In this case, one person who knew the secret bought stock, and then told a friend who also bought stock, and both made money unfairly.
Disclaimer: all facts are drawn from the SEC's own filings; the claims described are allegations unless and until a court rules or the parties settle, and some cases end in dismissal.
The SEC filed insider trading charges against Trijya Vakil and Neeraj Visen. Both defendants have consented to the entry of judgments against them, including injunctions from future violations. Monetary relief, if any, is to be determined by the Court. Vakil and Visen also pleaded guilty to criminal charges in parallel actions.
Named in this action: Trijya Vakil, Neeraj Visen.